🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Celebrating Fadi Sheban's graduation 🎉🍾🔥 So proud of you and your endless passion for knowledge and innovation. You will be greatly missed 👑 A future science superstar in the making

Finally out!!! – So proud of Dahlia Kushinsky & Manos Tsivourakis who demonstrate in a foundational study that the circuit function of sensory-induced transcription lies in driving downward Firing Rate Homeostasis via the daily normalization of E/I-ratio doi.org/10.1016/j.celr…

If you’re interested in our protocols for cell doublet quantification and imagestream analysis from our #BiCE paper, or if you have a bispecific engager of your own that you’d like to test, check out our new protocol from Rony Dahan with Ziv Porat published in STAR Protocols 🫧

An exciting advance in Type 1 diabetes First person to receive her own stem cells, reprogrammed with transcription factors, to reverse it! Cell sciencedirect.com/science/articl… nature nature.com/articles/d4158…

Exciting news! Incredible opportunity for cutting-edge metastasis research with my brilliant former colleague Ido Yofe - an exceptional scientist and wonderful person. 🚀

Biggest medical discoveries of the week (🧵) 1/8 Single dose CRISPR for hereditary angioedema, a genetic condition that causes unpredictable swelling attacks This phase 2, placebo-controlled randomised trial found that CRISPR editing of kallikrein (KLKB1) reduced angioedema

It is a great pleasure to announce today the launch of the NobsLab! Located at the University of Zurich, we will study microbiome-immune interactions and how they regulate diseases of the lung, in particular infection and chronic inflammation.

It was hard to say goodbye to the Amitlab family! Forever grateful to everyone, especially Ido, for the friendship, support, and great times. I couldn’t have asked for a better place to help me grow and push boundaries. Excited for the next chapter, and I'll miss you all dearly❤️

Today in Nature Biotechnology we report on the use of base and prime editing for high throughput interrogation of genetic variants in cancer. Excellent work by first authors Olivier Belli & Kyriaki Karava. 🧵👇 tinyurl.com/2js9dwyp ETH Zurich D-BSSE, ETH Zurich

I am honored to receive the Fondazione Pezcoller foundation- EACR Translational Cancer Research Award. It is truly inspirational when our research is recognized by the community and motivates us even further to push the boundaries of immunotherapies for currently incurable cancers.

Looking forward to connect with the local single cell enthusiasts in Heidelberg tomorrow! Thanks a lot for the invitation Saez-Rodriguez Group Julio Saez-Rodriguez Natalia Gabrielli and maria!

בעוד שנים ארוכות, כשנסתכל אחורה וננסה להבין איך צמח הפשיזם הישראלי ואיך הטרור היהודי זכה ללגיטימציה כל כך גדולה - נסתכל על הרגעים האלה, שבהם המרכז הישראלי, דמויות כמו גנץ, אייזנקוט ועידן רול(!), הצביעו ביחד עם נציגי הטרור היהודי בן גביר ולימור סון הר מלך על סיפוח של הגדה המערבית.

Are you an immunologist interested in spatially-resolved single cell technologies and generative modeling but dont know where to start? Check out our European Journal of Immunology review with Avital, Hosna, Robert Zeiser, IdoAmitLab, Yosef Lab & Tobias Wertheimer onlinelibrary.wiley.com/doi/10.1002/ej…

The Yofe Lab at Sheba is looking for scientists: 🥼Research Associate • PhD & MSc students 🎓 Our new cancer research group is focused on studying metastasis with cutting-edge tech. Interested? Send your CV & cover letter to: [email protected]

Amazing discovery!

We are beyond excited to share the first publication of our lab! We highlight the role of #neutrophils in shaping a more aggressive #TME through physical interactions with #breastcancer cells. The work was led by the talented Sandra Camargo 🎗️💔 & Ori Moskowitz 🧵nature.com/articles/s4301…

ZEB2 is a master switch controlling the tumor-associated macrophage program cell.com/cancer-cell/ab…

Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism" —the 1st human to undergo custom genome editing —outgrowth of decades of NIH funded research nejm.org/doi/full/10.10… nejm.org/doi/full/10.10… NEJM